Drug comparisons
Dapagliflozin vs Repaglinide
Compare Dapagliflozin (Farxiga) vs Repaglinide for type 2 diabetes: SGLT2 vs meglitinide differences in heart/kidney benefits, hypo risk, weight, and dosing.
No comparison dimensions are available for this page.
Clinical context
Triggered when adding second-line oral therapy after metformin or switching due to cardiovascular/renal disease, hypoglycemia risk or meal-related dosing needs in type 2 diabetes.
Bottom line
Dapagliflozin is generally preferred for most patients owing to proven heart and kidney benefits plus a safer hypoglycemia profile, though Repaglinide can fit cost-sensitive cases needing prandial flexibility without those comorbidities.
All medication comparisons